Alan Tan
Impact in
-
- Cancer Genomics and Diagnostics
- NF-κB Signaling Pathways
Papers in
- Oncology 22
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 4
- Cutaneous Melanoma Detection and Management 3
-
- Renal cell carcinoma treatment 10
- Prostate Cancer Treatment and Research 7
- Co-authors
- Marc B. Hershenson (6 shared papers)Anning Lin (2 shared papers)Limei Zhou (3 shared papers)Kristen Page (2 shared papers)Jing Li (1 shared paper)Huda Salman (2 shared papers)Jun Miyoshi (1 shared paper)Orlando DeLeon (1 shared paper)
- Journals
- Journal of Clinical Oncology (25 papers)Pediatric Research (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)Australasian Journal of Dermatology (1 paper)ESMO Open (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Alan Tan
46 papers receiving 456 citations
Peers
Comparison fields: 5 of 73
- Immunology and Allergy 29
- Cancer Research 61
- Oncology 103
- Hematology 42
- Pulmonary and Respiratory Medicine 110
Countries citing papers authored by Alan Tan
This map shows the geographic impact of Alan Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Tan more than expected).
Fields of papers citing papers by Alan Tan
This network shows the impact of papers produced by Alan Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Tan. The network helps show where Alan Tan may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 58 | |
| 2 | 2003 | 58 | |
| 3 | 2003 | 48 | |
| 4 | 2023 | 35 | |
| 5 | 2020 | 32 | |
| 6 | 2003 | 19 | |
| 7 | 2004 | 19 | |
| 8 | 2021 | 17 | |
| 9 | 2004 | 16 | |
| 10 | 2010 | 14 | |
| 11 | 2021 | 12 | |
| 12 | 2007 | 10 | |
| 13 | 2022 | 9 | |
| 14 | 2022 | 9 | |
| 15 | 2022 | 9 | |
| 16 | 2023 | 9 | |
| 17 | 2022 | 7 | |
| 18 | 2024 | 7 | |
| 19 | 2024 | 6 | |
| 20 | 2024 | 6 |
About Alan Tan
Alan Tan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Immunology, having authored 53 papers that have together received 461 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (14 papers), Cancer Genomics and Diagnostics (12 papers), Renal cell carcinoma treatment (10 papers), Prostate Cancer Treatment and Research (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers), Genetic factors in colorectal cancer (4 papers) and Cutaneous Melanoma Detection and Management (3 papers). The work is most often cited by research in Immunology and Allergy (29 citations), Cancer Research (61 citations), Oncology (103 citations), Hematology (42 citations) and Pulmonary and Respiratory Medicine (110 citations). Alan Tan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marc B. Hershenson, Anning Lin, Limei Zhou, Kristen Page, Jing Li, Jing Li, Huda Salman, Jun Miyoshi, Orlando DeLeon and Joseph S. Takahashi. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Research, Urologic Oncology Seminars and Original Investigations, Australasian Journal of Dermatology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.